259 related articles for article (PubMed ID: 19285278)
21. Thalidomid: current role in the treatment of non-plasma cell malignancies.
Kumar S; Witzig TE; Rajkumar SV
J Clin Oncol; 2004 Jun; 22(12):2477-88. PubMed ID: 15197211
[TBL] [Abstract][Full Text] [Related]
22. [A new treatment protocol targeting tumor vasculature--- metronomic chemotherapy combined radiotherapy].
Qiu H; Wang GM
Ai Zheng; 2007 Dec; 26(12):1392-6. PubMed ID: 18076810
[TBL] [Abstract][Full Text] [Related]
23. Chemotherapy-associated thrombosis.
Ashrani AA; Rajkumar SV
Cancer Treat Res; 2009; 148():181-206. PubMed ID: 19377925
[No Abstract] [Full Text] [Related]
24. Anti-cancer properties of low-molecular-weight heparin: preclinical evidence.
Mousa SA; Petersen LJ
Thromb Haemost; 2009 Aug; 102(2):258-67. PubMed ID: 19652876
[TBL] [Abstract][Full Text] [Related]
25. Microvascular endothelial cell heterogeneity: general concepts and pharmacological consequences for anti-angiogenic therapy of cancer.
Langenkamp E; Molema G
Cell Tissue Res; 2009 Jan; 335(1):205-22. PubMed ID: 18677515
[TBL] [Abstract][Full Text] [Related]
26. Chemotherapy and the tumor microenvironment: the contribution of circulating endothelial cells.
Bertolini F
Cancer Metastasis Rev; 2008 Mar; 27(1):95-101. PubMed ID: 18066648
[TBL] [Abstract][Full Text] [Related]
27. Anti-angiogenic therapy against gastrointestinal tract cancers.
Iwasaki J; Nihira S
Jpn J Clin Oncol; 2009 Sep; 39(9):543-51. PubMed ID: 19531544
[TBL] [Abstract][Full Text] [Related]
28. Tumour vascularisation: a druggable target.
Bishop-Bailey D
Curr Opin Pharmacol; 2009 Apr; 9(2):96-101. PubMed ID: 19056315
[TBL] [Abstract][Full Text] [Related]
29. Targeting tumor stroma and exploiting mature tumor vasculature to improve anti-cancer drug delivery.
Bouzin C; Feron O
Drug Resist Updat; 2007 Jun; 10(3):109-20. PubMed ID: 17452119
[TBL] [Abstract][Full Text] [Related]
30. Re: Anti-angiogenic therapy using thalidomide combined with chemotherapy in small cell lung cancer: a randomized, double-blind, placebo-controlled trial.
Musallam KM; Taher AT
J Natl Cancer Inst; 2009 Dec; 101(23):1657; author reply 1657-8. PubMed ID: 19858426
[No Abstract] [Full Text] [Related]
31. Coagulopathic complications in breast cancer.
Caine GJ; Stonelake PS; Rea D; Lip GY
Cancer; 2003 Oct; 98(8):1578-86. PubMed ID: 14534872
[TBL] [Abstract][Full Text] [Related]
32. The pathogenesis of venous thromboembolism in cancer: emerging links with tumour biology.
Winter PC
Hematol Oncol; 2006 Sep; 24(3):126-33. PubMed ID: 16783843
[TBL] [Abstract][Full Text] [Related]
33. Tumor angiogenesis in melanoma.
Marneros AG
Hematol Oncol Clin North Am; 2009 Jun; 23(3):431-46, vii-viii. PubMed ID: 19464595
[TBL] [Abstract][Full Text] [Related]
34. [Cancer chemotherapy and anticoagulant prophylaxis].
Blaskó G
Magy Onkol; 2008 Jun; 52(2):193-9. PubMed ID: 18640896
[TBL] [Abstract][Full Text] [Related]
35. Anti-angiogenic drugs currently in Phase II clinical trials for gynecological cancer treatment.
Wei XW; Zhang ZR; Wei YQ
Expert Opin Investig Drugs; 2013 Sep; 22(9):1181-92. PubMed ID: 23782133
[TBL] [Abstract][Full Text] [Related]
36. Cancer-Associated Thrombosis: Regulatory Mechanisms and Emerging Directions.
Prodger A; Saha P; Smith A; Evans CE
Adv Exp Med Biol; 2017; 906():115-122. PubMed ID: 27638621
[TBL] [Abstract][Full Text] [Related]
37. Clinical studies with anticoagulants to improve survival in cancer patients.
Gerotziafas GT; Papageorgiou C; Hatmi M; Samama MM; Elalamy I
Pathophysiol Haemost Thromb; 2008; 36(3-4):204-11. PubMed ID: 19176993
[TBL] [Abstract][Full Text] [Related]
38. New agents in medical oncology and the risk of venous thromboembolism.
Manzoni M; Bencardino K; Piovella F; Chatzileontiadou S; Delfanti S; Riccardi A; Danova M; Corazza GR
J Exp Clin Cancer Res; 2007 Jun; 26(2):185-94. PubMed ID: 17725097
[TBL] [Abstract][Full Text] [Related]
39. Cancer-associated thrombosis.
Sood SL
Curr Opin Hematol; 2009 Sep; 16(5):378-85. PubMed ID: 19606029
[TBL] [Abstract][Full Text] [Related]
40. Tumour angiogenesis: its mechanism and therapeutic implications in malignant gliomas.
Wong ML; Prawira A; Kaye AH; Hovens CM
J Clin Neurosci; 2009 Sep; 16(9):1119-30. PubMed ID: 19556134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
